Advertisement
Screener

CapsoVision, Inc (CV) Overview

CapsoVision, Inc (CV) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual -0.15; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -0.15; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.17; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -2.02; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$4.41$5.64$7.22$9.24$11.83$15.142025-11-062026-11-06$3.33$4.50$6.10$8.26$11.18$15.142025-07-022026-11-06$3.33$4.50$6.10$8.26$11.18$15.142025-07-022026-11-06$3.33$4.50$6.10$8.26$11.18$15.142025-07-022026-11-06$3.33$4.50$6.10$8.26$11.18$15.142025-07-022026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$6.31
Previous close
$6.69
Change
-$0.38
Change (%)
-5.68%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

CV
-37.31%
S&P 500
(m)

1 year

CV
+47.93%
S&P 500
(m)

3 years

CV
(m)
S&P 500
(m)

5 years

CV
(m)
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual -0.15

-2.57-1.92-1.27-0.620.0331 Mar 2025: estimate (m); actual -2.4931 Mar 2025(m)30 Jun 2025: estimate (m); actual -2.0230 Jun 2025(m)30 Sept 2025: estimate (m); actual -0.1730 Sept 2025(m)31 Mar 2026: estimate (m); actual -0.1531 Mar 2026(m)30 Jun 2026: estimate (m); actual -0.1530 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)-0.15(m)(m)
1 Jan 202631 Mar 2026(m)-0.15(m)(m)
1 Jul 202530 Sept 2025(m)-0.17(m)(m)
1 Apr 202530 Jun 2025(m)-2.02(m)(m)
1 Jan 202531 Mar 2025(m)-2.49(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -1.03

-9.93-7.66-5.39-3.12-0.8531 Dec 2024: estimate (m); actual -9.8531 Dec 2024(m)31 Dec 2025: estimate (m); actual -1.0331 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-1.03(m)(m)
1 Jan 202431 Dec 2024(m)-9.85(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 3.64M ■ Earnings -7.48M — Profit margin -205.35%

-9.34M-252.9%-4.45M-231.2%0.45M-209.4%5.34M-187.7%30 Sept 2025: revenue 3.54M; earnings -7.92M; profit margin -223.88%30 Sept 202531 Dec 2025: revenue 3.92M*; earnings -7.39M*; profit margin -188.72%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 2.79M; earnings -7.03M; profit margin -251.90%31 Mar 202630 Jun 2026: revenue 3.64M; earnings -7.48M; profit margin -205.35%30 Jun 2026

31 Dec 2025 ■ Revenue 13.55M ■ Earnings -25.32M — Profit margin -186.77%

-29.98M-187.8%-13.91M-181.3%2.15M-174.8%18.22M-168.3%31 Dec 2024: revenue 11.76M; earnings -19.90M; profit margin -169.26%31 Dec 202431 Dec 2025: revenue 13.55M; earnings -25.32M; profit margin -186.77%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$6.31(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$6.31High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning CV

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-12; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$-29.83M
Profit margin
-214.74%
Return on assets · 12 month
-212.19%
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
291.37K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
6.37%*
Total return · month
12.62%*
Total return · quarter
-11.13%*
Total return · half year
-10.77%*
Total return · year to date
-37.31%*
Total return · 1 year
47.93%*
Total return · 3 years
(m)
Total return · 5 years
(m)
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$13.89M
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

CapsoVision, Inc Overview

View more →

(m)

(m)

SEC CIK
1378325
Industry (SIC)
3845 Electromedical & Electrotherapeutic Apparatus
Country of operation
United States
Business address
18805 COX AVENUE SUITE 250, SARATOGA, California, 95070, United States
Fiscal year end
1231
Phone
(408) 370-4790

Similar stocks

Stock NameCountryMarket CapPE Ratio
Electromed, Inc. (ELMD)United States$0.233B31.13
EDAP TMS SA (FOCL)$0.171B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
Vivani Medical, Inc. (VANI)United States$0.111B
electroCore, Inc. (ECOR)United States$0.102B
Neuraxis, INC (NRXS)United States$0.097B
Nexalin Technology, Inc. (NXL)United States$0.094B
Streamex Corp. (STEX)United States$0.089B-0.19
Outset Medical, Inc. (OM)United States$0.059B-1.09
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B